- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,030GBP
- Drug Pipelines
- October 2020
- 87 Pages
Global
From €3364EUR$3,500USD£2,885GBP
- Report
- July 2022
- 65 Pages
Global
From €3364EUR$3,500USD£2,885GBP
Ibutamoren is a drug used to treat endocrine and metabolic disorders. It is a growth hormone secretagogue, meaning it stimulates the release of growth hormone from the pituitary gland. It is used to treat growth hormone deficiency, as well as other conditions such as Turner Syndrome, Prader-Willi Syndrome, and short stature due to Noonan Syndrome. Ibutamoren is also used to treat age-related muscle wasting and osteoporosis. It is available in both oral and injectable forms.
Ibutamoren is a relatively new drug, and the market is still developing. It is becoming increasingly popular as a treatment for endocrine and metabolic disorders, due to its effectiveness and safety profile. It is also being studied for its potential to treat other conditions, such as obesity and type 2 diabetes.
Some companies in the Ibutamoren market include Novo Nordisk, Pfizer, and Eli Lilly. Show Less Read more